An Amphiphilic Mimotope Vaccine to Enhance FDA-Approved Anti-CD19 CAR T Therapy
Exclusively Licensed
Invention type: Technology
/
Case number: #22096H
Researchers
Darrell J Irvine
/
Benjamin Cossette
/
Leyuan Ma
/
Naveen Mehta
/
Karl Dane Wittrup
Departments: David H Koch Institute for Integrative Cancer Res, Department of Chemical Engineering
Technology Areas: Biotechnology: Biomanufacturing, Synthetic Biology / Therapeutics: Proteins & Antibodies, Vaccines
Impact Areas: Healthy Living
-
chimeric antigen receptor-targeting ligands and uses thereof
United States of America | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.